Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
Local cerebral metabolic rates were determined by positron emission tomography and the deoxyglucose method in a group of 10 chronic schizophrenic subjects before and after somatic treatment and in eight normal subjects. Before treatment, schizophrenic subjects had markedly lower absolute metabolic activity than did normal controls in both frontal and temporal regions and a trend toward relative hyperactivity in the basal ganglia area. After treatment, their metabolic rates approached those seen in normal subjects in nearly all regions except frontal. Persistence of diminished frontal metabolism was manifested as significant relative hypofrontality. These findings suggest specific loci of aberrant cerebral functioning in chronic schizophrenia and the utility of positron emission tomography in characterizing these abnormalities.
D000328:Adult; D001479:Basal Ganglia / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D002908:Chronic Disease; D003847:Deoxyglucose / Q000031:analogs & derivatives / Q000378:metabolism; D005461:Fluorine; D019788:Fluorodeoxyglucose F18; D005625:Frontal Lobe / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011868:Radioisotopes; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D012565:Schizophrenic Psychology; D013702:Temporal Lobe / Q000378:metabolism; D013888:Thiothixene / Q000627:therapeutic use; D014055:Tomography, Emission-Computed
D011868:Radioisotopes; D019788:Fluorodeoxyglucose F18; D005461:Fluorine; D013888:Thiothixene; D003847:Deoxyglucose